FSPM Financials 07/16/2014 18:59:22
Fusion Pharm, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 594 308 227 -
Cost of Revenue 474 223 158 -
Gross Profit 121 86 69 -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 131 272 384 8
Non-Recurring Items - - - -
Other - - - -
Operating Income (10) (187) (315) (
Income From Continuing Operations
Add'l Income/Expense Items (9) (22) (78) 878
Earnings Before Interest and Tax (19) (208) (393) (
Interest Expense 23 26 10 -
Earnings Before Tax (42) (235) (402) (
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (42) (235) (304) 871
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (42) (235) (402) 871
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (42) (235) (402) 871